Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Becton Dickinson and Co.
Headquarters: Franklin Lakes, NJ, United States of America
Website: http://www.bd.com
Year Founded: 1895
Status: Public
Industry Sector: HealthTechnology
CEO: Thomas E. Polen, MBA
Number Of Employees: 74,000
Enterprise Value: $88,780,272,810
PE Ratio: 34.44
Exchange/Ticker 1: NYSE:BDX
Exchange/Ticker 2: N/A
Latest Market Cap: $63,626,244,096
BioCentury | Feb 14, 2024
Management Tracks
New CEOs for Enable, StromaCare
Plus: Philippakis joins GV as general partner, and updates from Verily, Meliora, Citryll and Silver Creek
BioCentury | Aug 26, 2022
Management Tracks
Leading China biotechs Everest, CStone announce CEO departures
Plus updates from BD, Sema4,
BioCentury | Jul 7, 2022
Management Tracks
Seghers joins CBC as it expands into Europe
Plus Kallyope promotes Pinto to CSO and updates from BD and Harpoon
BioCentury | Apr 28, 2022
Management Tracks
Marioni to lead computational effort at Genentech’s gRED
Plus new COO, CMO at I-Mab, updates from TwinStrand, Chimera, CyTek and more
BioCentury | Nov 30, 2021
Management Tracks
Tolstrup stepping up at Lundbeck
Plus: Neomorph, Becton Dickinson, Karuna, Ascentage and Hummingbird
BioCentury | Aug 13, 2021
Management Tracks
Mehra joins Myovant as chief financial and business officer
Plus: updates from Becton Dickinson, Sesen, Abeona, Quotient, Adverum and more
BioCentury | Mar 25, 2021
Management Tracks
Slaoui resigns from Vaxcyte, Centessa; plus moves at HHS, Fate, Inotrem, Immuneering, SwanBio and more
In the wake of sexual harassment allegations, former Operation Warp Speed leader Moncef Slaoui has resigned as chairman of Vaxcyte Inc. (NASDAQ:PCVX) and as CSO and adviser at Centessa Pharmaceuticals
BioCentury | Mar 10, 2021
Management Tracks
Ex-BARDA Director Bright joins Rockefeller Foundation; plus Lilly, Q32 Bio, Apollomics, Axial and Grip
Rick Bright joined The Rockefeller Foundation as SVP of pandemic prevention and response to establish an institute that seeks to prevent future pandemics by responding to the earliest signs of a
BioCentury | Jan 8, 2021
Management Tracks
PacBio hires pair of Illumina vets; plus Ionis, Sana, Purespring, eFFECTOR, Constellation, T2, MiNA, Vividion, Pharma Two B and WIB
Pacific Biosciences of California Inc. (NASDAQ:PACB) filled two newly created posts via the hiring of a pair of Illumina Inc. (NASDAQ:ILMN) veterans: Mark Van Oene as COO and Peter Fromen as chief
Items per page:
1 - 10 of 238